143 related articles for article (PubMed ID: 20868364)
1. Imaging of ABC transporter function and expression.
Colabufo NA; van Waarde A
Curr Top Med Chem; 2010; 10(17):1701-2. PubMed ID: 20868364
[No Abstract] [Full Text] [Related]
2. Importance of ABC Transporters in Drug Development.
Benadiba M; Maor Y
Curr Pharm Des; 2016; 22(38):5817-5829. PubMed ID: 27514710
[TBL] [Abstract][Full Text] [Related]
3. Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier.
Raaphorst RM; Windhorst AD; Elsinga PH; Colabufo NA; Lammertsma AA; Luurtsema G
Clin Pharmacol Ther; 2015 Apr; 97(4):362-71. PubMed ID: 25669763
[TBL] [Abstract][Full Text] [Related]
4. PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and Strategies.
Luurtsema G; Elsinga P; Dierckx R; Boellaard R; van Waarde A
Curr Pharm Des; 2016; 22(38):5779-5785. PubMed ID: 27568733
[TBL] [Abstract][Full Text] [Related]
5. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
[TBL] [Abstract][Full Text] [Related]
6. Probing multidrug resistance P-glycoprotein transporter activity with SPECT radiopharmaceuticals.
Piwnica-Worms D; Sharma V
Curr Top Med Chem; 2010; 10(17):1834-45. PubMed ID: 20645914
[TBL] [Abstract][Full Text] [Related]
7. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
Yu M; Ocana A; Tannock IF
Cancer Metastasis Rev; 2013 Jun; 32(1-2):211-27. PubMed ID: 23093326
[TBL] [Abstract][Full Text] [Related]
8. Defeating drug resistance in cancer.
Gottesman MM; Ludwig J; Xia D; Szakács G
Discov Med; 2006 Feb; 6(31):18-23. PubMed ID: 17234123
[TBL] [Abstract][Full Text] [Related]
9. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
Wei N; Sun H; Liu GT
Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
[TBL] [Abstract][Full Text] [Related]
10. Novel insights into targeting ATP-binding cassette transporters for antitumor therapy.
Gatti L; Cossa G; Beretta GL; Zaffaroni N; Perego P
Curr Med Chem; 2011; 18(27):4237-49. PubMed ID: 21838682
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and DNA damage: Probing pathways to cancer and neurodegeneration.
Makvandi M; Sellmyer MA; Mach RH
Drug Discov Today Technol; 2017 Nov; 25():37-43. PubMed ID: 29233266
[TBL] [Abstract][Full Text] [Related]
12. Reversing agents for ATP-binding cassette drug transporters.
Lee CH
Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
[TBL] [Abstract][Full Text] [Related]
13. ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy.
Dlugosz A; Janecka A
Curr Pharm Des; 2016; 22(30):4705-4716. PubMed ID: 26932159
[TBL] [Abstract][Full Text] [Related]
14. What does a picture tell? In vivo imaging of ABC transporter function.
Bankstahl JP
Drug Discov Today Technol; 2014 Jun; 12():e113-9. PubMed ID: 25027369
[TBL] [Abstract][Full Text] [Related]
15. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
16. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials.
Colabufo NA; Berardi F; Cantore M; Contino M; Inglese C; Niso M; Perrone R
J Med Chem; 2010 Mar; 53(5):1883-97. PubMed ID: 19924994
[No Abstract] [Full Text] [Related]
18. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.
Kathawala RJ; Gupta P; Ashby CR; Chen ZS
Drug Resist Updat; 2015 Jan; 18():1-17. PubMed ID: 25554624
[TBL] [Abstract][Full Text] [Related]
19. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
20. Classical resistance mechanisms.
Jäeger W
Int J Clin Pharmacol Ther; 2009 Jan; 47(1):46-8. PubMed ID: 19203536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
